Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Zurakowski, Ph.D.

Co-Author

This page shows the publications co-authored by David Zurakowski and Marsha Moses.
Connection Strength

2.235
  1. Association of Longitudinal Changes in Symptoms and Urinary Biomarkers in Patients with Urological Chronic Pelvic Pain Syndrome: A MAPP Research Network Study. J Urol. 2021 02; 205(2):514-523.
    View in: PubMed
    Score: 0.233
  2. Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer. BMC Cancer. 2015 Apr 11; 15:259.
    View in: PubMed
    Score: 0.159
  3. Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo. Am J Pathol. 2014 Jul; 184(7):2099-110.
    View in: PubMed
    Score: 0.151
  4. Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo. Blood. 2013 Jan 24; 121(4):707-15.
    View in: PubMed
    Score: 0.135
  5. Potential of fluorescent metalloproteinase substrates for cancer detection. Clin Biochem. 2011 Dec; 44(17-18):1434-9.
    View in: PubMed
    Score: 0.125
  6. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. Gynecol Oncol. 2011 Nov; 123(2):295-300.
    View in: PubMed
    Score: 0.124
  7. ADAM12 transmembrane and secreted isoforms promote breast tumor growth: a distinct role for ADAM12-S protein in tumor metastasis. J Biol Chem. 2011 Jun 10; 286(23):20758-68.
    View in: PubMed
    Score: 0.121
  8. Matrix metalloproteinases are elevated in the urine of patients with endometriosis. Fertil Steril. 2010 Nov; 94(6):2343-6.
    View in: PubMed
    Score: 0.112
  9. Matrix metalloproteinases in the urine and tissue of patients with juvenile polyps: potential biomarkers for the presence of polyps. J Pediatr Gastroenterol Nutr. 2009 Apr; 48(4):405-11.
    View in: PubMed
    Score: 0.105
  10. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A. 2009 Mar 10; 106(10):3913-8.
    View in: PubMed
    Score: 0.104
  11. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res. 2008 Oct 15; 14(20):6610-7.
    View in: PubMed
    Score: 0.101
  12. Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008 Aug; 14(8):1091-6.
    View in: PubMed
    Score: 0.100
  13. Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1034-42.
    View in: PubMed
    Score: 0.098
  14. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res. 2008 Apr 15; 14(8):2378-86.
    View in: PubMed
    Score: 0.098
  15. Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension. Chest. 2005 Dec; 128(6 Suppl):572S.
    View in: PubMed
    Score: 0.083
  16. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics. 2005 Jul; 116(1):38-45.
    View in: PubMed
    Score: 0.081
  17. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem. 2004 Dec 03; 279(49):51323-30.
    View in: PubMed
    Score: 0.077
  18. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res. 1998 Apr 01; 58(7):1395-9.
    View in: PubMed
    Score: 0.049
  19. Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. BJU Int. 2017 07; 120(1):130-142.
    View in: PubMed
    Score: 0.046
  20. A quantitative method for screening and identifying molecular targets for nanomedicine. J Control Release. 2017 Oct 10; 263:57-67.
    View in: PubMed
    Score: 0.046
  21. ICAM-1 as a molecular target for triple negative breast cancer. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14710-5.
    View in: PubMed
    Score: 0.038
  22. Correlation between prenatal urinary matrix metalloproteinase activity and the degree of kidney damage in a large animal model of congenital obstructive uropathy. J Pediatr Surg. 2010 Jun; 45(6):1120-5.
    View in: PubMed
    Score: 0.028
  23. Extracellular matrix dynamics associated with tissue-engineered intravascular sclerotherapy. J Pediatr Surg. 2006 Apr; 41(4):757-62.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.